Algernon Pharmaceuticals (TSE:AGN) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Algernon Pharmaceuticals, a Canadian drug development firm, has successfully completed a non-brokered private placement, raising $235,200 for working capital purposes. Insider participation added $60,000 to the raise, classified as a ‘related party transaction,’ but complied with regulatory exemptions due to the transaction’s size relative to the company’s market cap.
For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money